KOREA PHARMA Co., Ltd.

A032300

KR7032300006

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
19,000 ^KRW	-1.09%		-1.91%	-19.66%

2023	Astrogen Co.,Ltd. announced that it has received KRW 2.999998662 billion in funding from KOREA PHARMA Co., Ltd.	CI
2023	KOREA PHARMA Co., Ltd. announced that it has received KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd.	CI

KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) added to S&P Global BMI Index

September 20, 2021 at 05:00 am

Latest news about KOREA PHARMA Co., Ltd.

Astrogen Co.,Ltd. announced that it has received KRW 2.999998662 billion in funding from KOREA PHARMA Co., Ltd.	11-29	CI
KOREA PHARMA Co., Ltd. announced that it has received KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd.	11-27	CI
KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd. and others	11-23	CI
Astrogen Co.,Ltd. announced that it expects to receive KRW 2.999998662 billion in funding from KOREA PHARMA Co., Ltd.	11-13	CI
KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) dropped from S&P Global BMI Index	18/09/23	CI
KOREA PHARMA Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
KOREA PHARMA Co., Ltd. announced that it has received KRW 50 billion in funding	25/10/21	CI
KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 50 billion in funding	21/10/21	CI
KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) added to S&P Global BMI Index	20/09/21	CI
KOREA PHARMA Co., Ltd. has completed an IPO in the amount of KRW 29.187 billion.	04/08/20	CI
KOREA PHARMA Co., Ltd. has filed an IPO.	13/04/20	CI

Korea Pharma Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medicinal products. The Company's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KOREA PHARMA CO., LTD.	-19.66%	156M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals

KOREA PHARMA Co., Ltd.

Equities

A032300

KR7032300006

Pharmaceuticals

KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) added to S&P Global BMI Index

Latest news about KOREA PHARMA Co., Ltd.

Chart KOREA PHARMA Co., Ltd.

Company Profile

Income Statement Evolution

Chiffre d''affaires - Rate of surprise

Sector Other Pharmaceuticals